Our CEO Daniele Foresti is excited to be back in his home country, Italy, for the Italian Tech Weekend. A great opportunity to connect with international and Italian startup and VC community to talk about current and future trends in innovation and tech https://t.co/O5rPmG6dFM

Thank you for highlighting our work, which was led by Daniele Foresti. He co-founded @AcousticaBio to harness this advance for drug delivery🙏

Join tomorrow the Lab-to-Launch Lounge by @innovationlab @hseas @HarvardTechXfer and hear from our CEO and Co-Founder Daniele Foresti, and Jasper Neggers, Founder and CSO of Promakhos Therapeutics, on how they launched their research out from Harvard labs https://t.co/p4LVryAxs1

Congratulations to @JenniferALewis1 and Pam Silver on being named Leading Innovators and Entrepreneurs to Follow by @bios_community on their list of Top Women Academic Entrepreneurs #Entrepreneur #innovation #InternationalWomansDay2023

Congratulations, Daniele Foresti @AcousticaBio 🌟

Big shout out to our CEO and Founder Daniele Foresti for being nominated as one of the 2022 Wyss Lumineers! Congratulations to the whole class of talents part of the Wyss Institute at Harvard University community

Congratulations to 2022 class of Wyss Lumineers! These community members embody our mission to transform healthcare and the environment by developing innovative technologies & accelerating their translation into commercial products through startups.

Fun Fact: Louie shares home office with a caique named Ollie, who loves sitting on his shoulder while listening to Zoom calls

Louie believes Acoustica technology vastly expands the available biomaterials, biologics and polymerization strategies for developing new products for the life sciences

Louie would love to invent and develop therapeutic applications using Acoustica printing technology. A technology that offers access to drug delivery and bioprinting concepts previously inaccessible because of the physical properties of available biocompatible starting materials

Louie remained in the Boston area ever since – doing R&D work at startups and at pharma companies. He has successfully guided several research ideas from bench to clinical testing and to eventual approval by the FDA. He has 30+ issued US patents to date

Meet the Team: Luis Avila, CSO. Louie grew up in the Philippines, crossed the Pacific to pursue his PhD in Organic Chemistry at @Stanford Univ, then crossed the US continent to join Prof George Whitesides group at @Harvard Univ for his postdoc

Since his introduction to AcousticaBio’s team at the MassChallenge as a mentor, he was intrigued by the challenge of a large payload in a nano-engineered microsphere. Fun Fact: Eyal has 4 bees hives and 5 chickens #meettheteam #advisoryboard #Entrepreneur

Dr. Ron facilitated the formation of Cerebrotec, Combinent Biomedical Systems, Sensei Biomaterials, just to name few. He thrives at the crossroad of drug eluting medical devices - a creative combination of pharmaceutical sciences with engineering.

Meet the team: @EyalSRon, Board and Advisory Board member. Dr Ron is a visionary serial entrepreneur who led multiple start-ups from conception to exit. He creates tremendous value by effective mentoring while accelerating the timeline toward the value inflection points.

Joining AcousticaBio is an opportunity to further the goal of improving patients’ quality of life by increasing their access to life-saving treatment, something that I believe should be universally accessible. Fun fact: Jet can use chopsticks with both hands, simultaneously

Meet the Team: Jet Takayama, Operations Coordinator. Operations professional&graphic artist with a background in supply chain for tech. They have worked in supply chain&operations at RightHand Robotics,Amazon Prime Air, developing solutions at critical stages of company growth

Concertians, friends, mentors, and investors assembled for Gala_002 to celebrate our 2nd birthday. Cheers to our team—Ensemble No.1!—and our incredibly supportive ecosystem of humans!

Fun fact: Daniel grew up in Bogota, Colombia and lived there until he was 18

Daniel would love to see AcousticaBio succeed and improve the lives of millions of patients by replacing IV-delivered drugs (expensive, not self-administered, relatively painful) with subcutaneous injections (cost efficient, self administered, less painful)